May 28, 2019 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Sun Pharma Q4 FY '19 Financial Results Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Nimish Desai. Thank you. And over to you, sir.
Nimish Desai - Sun Pharmaceutical Industries Limited - Head of IR
Thank you. Good evening, and a warm welcome to our fourth quarter FY '19 earnings call. I'm Nimish from the Sun Pharma Investor Relations team. We hope you've received the Q4 financials and the press release that was sent out earlier in the day. These are also available on our website. We have with us Mr. Dilip Shanghvi, Managing Director; Mr. Sudhir Valia, Whole-Time Director; Mr. Kal Sundaram, Whole-Time Director and CEO, India, Emerging Markets and Consumer Healthcare; and Mr. Abhay Gandhi, CEO of North America.
Today, the team will discuss performance highlights, update on strategies and respond to any questions that you may have. As is usual, for the ease of discussion, we will look at the consolidated
Full Year 2019 Sun Pharmaceutical Industries Ltd Earnings Call Transcript
Mar 20, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers